83 related articles for article (PubMed ID: 23093559)
1. Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis.
Proverbs-Singh T; Chiu SK; Liu Z; Seng S; Sonpavde G; Choueiri TK; Tsao CK; Yu M; Hahn NM; Oh WK; Galsky MD
J Natl Cancer Inst; 2012 Dec; 104(23):1837-40. PubMed ID: 23093559
[TBL] [Abstract][Full Text] [Related]
2. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.
Moore RA; Adel N; Riedel E; Bhutani M; Feldman DR; Tabbara NE; Soff G; Parameswaran R; Hassoun H
J Clin Oncol; 2011 Sep; 29(25):3466-73. PubMed ID: 21810688
[TBL] [Abstract][Full Text] [Related]
3. Association of immune checkpoint inhibitors therapy with arterial thromboembolic events in cancer patients: A retrospective cohort study.
Zhu J; Chen Y; Zhang Y; Wang W; Wang Y; Lu Z; Zhang Y; Lei H; Li D; Long B; Liu H
Cancer Med; 2023 Sep; 12(18):18531-18541. PubMed ID: 37584246
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.
Seng S; Liu Z; Chiu SK; Proverbs-Singh T; Sonpavde G; Choueiri TK; Tsao CK; Yu M; Hahn NM; Oh WK; Galsky MD
J Clin Oncol; 2012 Dec; 30(35):4416-26. PubMed ID: 23150697
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients: Systematic Review and Meta-Analysis.
Xu Y; Cole K; Collins E; Moledina A; Mallity C; Carrier M
JACC CardioOncol; 2023 Aug; 5(4):520-532. PubMed ID: 37614584
[TBL] [Abstract][Full Text] [Related]
6. Case of ST-Elevation Myocardial Infarction in a 32-Year-Old Male Receiving Bleomycin, Etoposide, and Cisplatin Chemotherapy for Embryonal Carcinoma.
Bassil E; Singh H; Ahmed O; Parikh S
Cureus; 2023 Jun; 15(6):e40089. PubMed ID: 37425586
[TBL] [Abstract][Full Text] [Related]
7. One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis).
Awano N; Okano T; Kawachi R; Matsumoto M; Kimura T; Takita A; Oba MS; Kunitoh H
JTO Clin Res Rep; 2022 Sep; 3(9):100392. PubMed ID: 36089919
[TBL] [Abstract][Full Text] [Related]
8. Cancer Therapies and Vascular Toxicities.
Meilhac A; Cautela J; Thuny F
Curr Treat Options Oncol; 2022 Mar; 23(3):333-347. PubMed ID: 35244888
[TBL] [Abstract][Full Text] [Related]
9. Population-based analysis of perioperative chemotherapy use, interventions requiring hospitalization and atheroembolic events among patients with non-metastatic muscle-invasive bladder cancer.
Benidir T; Herrera-Caceres J; Wallis C; Lajkosz K; Fleshner N
Cancer Med; 2021 Apr; 10(8):2636-2644. PubMed ID: 33710797
[TBL] [Abstract][Full Text] [Related]
10. Cancer Therapy-Associated Thrombosis.
Grover SP; Hisada YM; Kasthuri RS; Reeves BN; Mackman N
Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1291-1305. PubMed ID: 33567864
[TBL] [Abstract][Full Text] [Related]
11. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic Thromboembolism and Thrombophilia: Significance in Visceral Medicine.
Pfrepper C
Visc Med; 2020 Aug; 36(4):280-287. PubMed ID: 33005653
[TBL] [Abstract][Full Text] [Related]
13. Multimodality Imaging Diagnosis of Multiple Ventricular Thrombosis and Massive Stroke after Gemcitabine and Cisplatin Chemotherapy for Urothelial Cancer.
Bassareo PP; Cocco D; Cadeddu C; Mercuro G
J Cardiovasc Echogr; 2019; 29(2):71-74. PubMed ID: 31392124
[TBL] [Abstract][Full Text] [Related]
14. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Grilz E; Mauracher LM; Posch F; Königsbrügge O; Zöchbauer-Müller S; Marosi C; Lang I; Pabinger I; Ay C
Br J Haematol; 2019 Jul; 186(2):311-320. PubMed ID: 30968400
[TBL] [Abstract][Full Text] [Related]
15. Severe intestinal ischemia during chemotherapy for small cell lung cancer.
Legius B; Nackaerts K
Lung Cancer Manag; 2017 Dec; 6(3):87-91. PubMed ID: 30643574
[TBL] [Abstract][Full Text] [Related]
16. Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
Grilz E; Königsbrügge O; Posch F; Schmidinger M; Pirker R; Lang IM; Pabinger I; Ay C
Haematologica; 2018 Sep; 103(9):1549-1556. PubMed ID: 29794142
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.
Zareba P; Duivenvoorden WCM; Pinthus JH
Bladder Cancer; 2018 Apr; 4(2):139-147. PubMed ID: 29732385
[TBL] [Abstract][Full Text] [Related]
18. The use of and adherence to CTCAE v3.0 in cancer clinical trial publications.
Zhang S; Chen Q; Wang Q
Oncotarget; 2016 Oct; 7(40):65577-65588. PubMed ID: 27564109
[TBL] [Abstract][Full Text] [Related]
19. Use and misuse of common terminology criteria for adverse events in cancer clinical trials.
Zhang S; Liang F; Tannock I
BMC Cancer; 2016 Jul; 16():392. PubMed ID: 27377548
[TBL] [Abstract][Full Text] [Related]
20. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.
Galsky MD; Posner M; Holcombe RF; Lee KM; Misiukiewicz K; Tsao CK; Godbold J; Soto R; Gimpel-Tetra K; Lowe N; Oh WK
Cancer Chemother Pharmacol; 2014 Sep; 74(3):465-71. PubMed ID: 25023489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
